778-Som-Lalit Institute Of Business Management - Gujarat ...

• There is low investment in innovative R & D among Indian companies as
compared to foreign companies
7) Bad brand image:
• Bad brand image of Indian Pharmaceutical merchandise in the USA, United
Kingdom & other western countries which is obstructing exports.
8) Low level of Biotechnology:
• Indian companies face hindrance in terms of very low level of Biotechnology
in India and also for New Drug Discovery Systems
9) Lack of experience:
• India lacks experience in International Trade in this sector
10) Lack of product patent:
• Indian pharmaceutical sector has been blemished by be short of of product
patent
• This prevents global pharmaceutical companies to initiate new drugs in the
country and discourages novelty and drug discovery.
• But this has provided an upper hand to the Indian pharmaceutical companies.
Opportunities:
1) The Government of Qatar will continue to maintain high levels of capital
spending:
• The Government of Qatar will carry on upholding high levels of capital
expenditure on education and health.
• The government plans to invest $9.9 billion in these sectors in the 2012/2013
fiscal year, accounting for 15% of its 2010/2011 fiscal budget.
17 | P a g e